Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonistHAN, G; QUILLAN, J. M; CARLSON, K et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 5, pp 810-819, issn 0022-2623, 10 p.Article

Newly discovered stereochemical requirements in the side-chain conformation of δ opioid agonists fro recognizing opioid δ receptorsXINHUA QIAN; KÖVER, K. E; YAMAMURA, H. I et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 12, pp 1746-1757, issn 0022-2623Article

Antinociceptive and behavioral effects of synthetic deltorphin analogsNEGRI, L; NOVIELLO, L; NOVIELLO, V et al.European journal of pharmacology. 1996, Vol 296, Num 1, pp 9-16, issn 0014-2999Article

Agonist and antagonist profiles of [D-Ala², Glu⁴]deltorphin and its [Cys⁴]- and [Ser⁴]-substituted derivatives : further evidence of opioid delta receptor multiplicityHORAN, P. J; WILD, K. D; MISICKA, A et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 2, pp 896-902, issn 0022-3565Article

Opioid receptor selectivity alteration by single residue replacement : synthesis and activity profile of [Dmt¹]deltorphin BGUERRINI, R; CAPASSO, A; SORRENTINO, L et al.European journal of pharmacology. 1996, Vol 302, Num 1-3, pp 37-42, issn 0014-2999Article